Scholarlink

<p>The escalating global threat of antimicrobial resistance (AMR) necessitates a paradigm shift towards rapid and scalable diagnostic technologies. Conventional antimicrobial susceptibility testing (AST) methods, while reliable, are hindered by prolonged turnaround times (often 16–24&#xa0;h) and complex workflows, limiting their utility at the point-of-care (POC). Label-free phenotypic AST methods integrated within microfluidic platforms present a compelling alternative, enabling real-time, high-throughput monitoring of bacterial responses without the need for costly or time-consuming fluorescent labels and reagents. This review provides a comprehensive analysis and comparative evaluation of four primary label-free detection modalities: electrical impedance sensing, light scattering, surface-enhanced Raman spectroscopy (SERS), and machine vision powered by artificial intelligence (AI). We critically examine the principles of each technique, its integration with microfluidics, and its performance, highlighting studies that have demonstrated AST results in critically short timeframes (&lt; 2–4&#xa0;h) with high accuracy. Furthermore, we uniquely synthesize progress in commercial translation, discuss persistent challenges such as standardization and sample preparation, and provide a strengths, weaknesses, opportunities, and threats&#xa0;(SWOT) analysis to chart the future trajectory of the field. By offering a critical roadmap that bridges fundamental innovation with clinical application, this review demonstrates the potential of label-free microfluidic systems to deliver reagent-free, rapid, and scalable diagnostic solutions in the fight against AMR.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Label-free phenotypic antimicrobial susceptibility testing on microfluidic platforms: a review of advances and translation

  • 期刊论文

  • 发表日期：

    2025年11月13日

查看全文
  • Muhammad Usman Abubakar,
  • Suleiman Halima Abdullahi,
  • Mengqiu Xiong,
  • Bangshun He

摘要

The escalating global threat of antimicrobial resistance (AMR) necessitates a paradigm shift towards rapid and scalable diagnostic technologies. Conventional antimicrobial susceptibility testing (AST) methods, while reliable, are hindered by prolonged turnaround times (often 16–24 h) and complex workflows, limiting their utility at the point-of-care (POC). Label-free phenotypic AST methods integrated within microfluidic platforms present a compelling alternative, enabling real-time, high-throughput monitoring of bacterial responses without the need for costly or time-consuming fluorescent labels and reagents. This review provides a comprehensive analysis and comparative evaluation of four primary label-free detection modalities: electrical impedance sensing, light scattering, surface-enhanced Raman spectroscopy (SERS), and machine vision powered by artificial intelligence (AI). We critically examine the principles of each technique, its integration with microfluidics, and its performance, highlighting studies that have demonstrated AST results in critically short timeframes (< 2–4 h) with high accuracy. Furthermore, we uniquely synthesize progress in commercial translation, discuss persistent challenges such as standardization and sample preparation, and provide a strengths, weaknesses, opportunities, and threats (SWOT) analysis to chart the future trajectory of the field. By offering a critical roadmap that bridges fundamental innovation with clinical application, this review demonstrates the potential of label-free microfluidic systems to deliver reagent-free, rapid, and scalable diagnostic solutions in the fight against AMR.

Graphical Abstract